Targeting Mitochondria by Plant Secondary Metabolites: A Promising Strategy in Combating Parkinson’s Disease

Parkinson’s disease (PD) is one of the most prevalent and debilitating neurodegenerative conditions, and is currently on the rise. Several dysregulated pathways are behind the pathogenesis of PD; however, the critical targets remain unclear. Accordingly, there is an urgent need to reveal the key dys...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sajad Fakhri, Sadaf Abdian, Seyede Nazanin Zarneshan, Esra Küpeli Akkol, Mohammad Hosein Farzaei, Eduardo Sobarzo-Sánchez
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/25b65ef61a344aacaff75c0375d72c64
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:25b65ef61a344aacaff75c0375d72c64
record_format dspace
spelling oai:doaj.org-article:25b65ef61a344aacaff75c0375d72c642021-11-25T17:57:59ZTargeting Mitochondria by Plant Secondary Metabolites: A Promising Strategy in Combating Parkinson’s Disease10.3390/ijms2222125701422-00671661-6596https://doaj.org/article/25b65ef61a344aacaff75c0375d72c642021-11-01T00:00:00Zhttps://www.mdpi.com/1422-0067/22/22/12570https://doaj.org/toc/1661-6596https://doaj.org/toc/1422-0067Parkinson’s disease (PD) is one of the most prevalent and debilitating neurodegenerative conditions, and is currently on the rise. Several dysregulated pathways are behind the pathogenesis of PD; however, the critical targets remain unclear. Accordingly, there is an urgent need to reveal the key dysregulated pathways in PD. Prevailing reports have highlighted the importance of mitochondrial and cross-talked mediators in neurological disorders, genetic changes, and related complications of PD. Multiple pathophysiological mechanisms of PD, as well as the low efficacy and side effects of conventional neuroprotective therapies, drive the need for finding novel alternative agents. Recently, much attention has been paid to using plant secondary metabolites (e.g., flavonoids/phenolic compounds, alkaloids, and terpenoids) in the modulation of PD-associated manifestations by targeting mitochondria. In this line, plant secondary metabolites have shown promising potential for the simultaneous modulation of mitochondrial apoptosis and reactive oxygen species. This review aimed to address mitochondria and multiple dysregulated pathways in PD by plant-derived secondary metabolites.Sajad FakhriSadaf AbdianSeyede Nazanin ZarneshanEsra Küpeli AkkolMohammad Hosein FarzaeiEduardo Sobarzo-SánchezMDPI AGarticleneurodegenerative diseaseParkinson’s diseasesecondary metabolitesphytochemicalsmitochondriasignaling pathwayBiology (General)QH301-705.5ChemistryQD1-999ENInternational Journal of Molecular Sciences, Vol 22, Iss 12570, p 12570 (2021)
institution DOAJ
collection DOAJ
language EN
topic neurodegenerative disease
Parkinson’s disease
secondary metabolites
phytochemicals
mitochondria
signaling pathway
Biology (General)
QH301-705.5
Chemistry
QD1-999
spellingShingle neurodegenerative disease
Parkinson’s disease
secondary metabolites
phytochemicals
mitochondria
signaling pathway
Biology (General)
QH301-705.5
Chemistry
QD1-999
Sajad Fakhri
Sadaf Abdian
Seyede Nazanin Zarneshan
Esra Küpeli Akkol
Mohammad Hosein Farzaei
Eduardo Sobarzo-Sánchez
Targeting Mitochondria by Plant Secondary Metabolites: A Promising Strategy in Combating Parkinson’s Disease
description Parkinson’s disease (PD) is one of the most prevalent and debilitating neurodegenerative conditions, and is currently on the rise. Several dysregulated pathways are behind the pathogenesis of PD; however, the critical targets remain unclear. Accordingly, there is an urgent need to reveal the key dysregulated pathways in PD. Prevailing reports have highlighted the importance of mitochondrial and cross-talked mediators in neurological disorders, genetic changes, and related complications of PD. Multiple pathophysiological mechanisms of PD, as well as the low efficacy and side effects of conventional neuroprotective therapies, drive the need for finding novel alternative agents. Recently, much attention has been paid to using plant secondary metabolites (e.g., flavonoids/phenolic compounds, alkaloids, and terpenoids) in the modulation of PD-associated manifestations by targeting mitochondria. In this line, plant secondary metabolites have shown promising potential for the simultaneous modulation of mitochondrial apoptosis and reactive oxygen species. This review aimed to address mitochondria and multiple dysregulated pathways in PD by plant-derived secondary metabolites.
format article
author Sajad Fakhri
Sadaf Abdian
Seyede Nazanin Zarneshan
Esra Küpeli Akkol
Mohammad Hosein Farzaei
Eduardo Sobarzo-Sánchez
author_facet Sajad Fakhri
Sadaf Abdian
Seyede Nazanin Zarneshan
Esra Küpeli Akkol
Mohammad Hosein Farzaei
Eduardo Sobarzo-Sánchez
author_sort Sajad Fakhri
title Targeting Mitochondria by Plant Secondary Metabolites: A Promising Strategy in Combating Parkinson’s Disease
title_short Targeting Mitochondria by Plant Secondary Metabolites: A Promising Strategy in Combating Parkinson’s Disease
title_full Targeting Mitochondria by Plant Secondary Metabolites: A Promising Strategy in Combating Parkinson’s Disease
title_fullStr Targeting Mitochondria by Plant Secondary Metabolites: A Promising Strategy in Combating Parkinson’s Disease
title_full_unstemmed Targeting Mitochondria by Plant Secondary Metabolites: A Promising Strategy in Combating Parkinson’s Disease
title_sort targeting mitochondria by plant secondary metabolites: a promising strategy in combating parkinson’s disease
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/25b65ef61a344aacaff75c0375d72c64
work_keys_str_mv AT sajadfakhri targetingmitochondriabyplantsecondarymetabolitesapromisingstrategyincombatingparkinsonsdisease
AT sadafabdian targetingmitochondriabyplantsecondarymetabolitesapromisingstrategyincombatingparkinsonsdisease
AT seyedenazaninzarneshan targetingmitochondriabyplantsecondarymetabolitesapromisingstrategyincombatingparkinsonsdisease
AT esrakupeliakkol targetingmitochondriabyplantsecondarymetabolitesapromisingstrategyincombatingparkinsonsdisease
AT mohammadhoseinfarzaei targetingmitochondriabyplantsecondarymetabolitesapromisingstrategyincombatingparkinsonsdisease
AT eduardosobarzosanchez targetingmitochondriabyplantsecondarymetabolitesapromisingstrategyincombatingparkinsonsdisease
_version_ 1718411790315945984